Latest Headlines

  1. U.S. District Court Suspends Massachusetts’ Zohydro Ban

    A U.S. District court issued a ruling that a Massachusetts ban on Zohydro, an opioid pain reliever, is unconstitutional.

  2. WHO Launches Good Governance For Medicine (GGM) Programme In Pakistan

    The World Health Organization (WHO) has launched the global Good Governance for Medicine (GGM) Programme in Pakistan.

  3. Aesica Implements Serialization Services In Italy

    Aesica, an Italian pharmaceutical contract development and manufacturing organization (CDMO), announced in a press release that it has begun producing serialized drugs for one of its partners.

  4. Are mega M&As Back In Pharma?

    “The pharmaceutical industry is witnessing a new wave of mergers and acquisitions activities, especially mega M&As.

  5. Beckman Coulter Life Sciences To Acquire Cytometer Maker Xitogen

    Beckman Coulter Life Sciences has entered into an agreement to acquire Xitogen Technologies Inc. together with Cytojene Corporation. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with both a strong operational base in the growing China market and a high quality research instrument to round out their world-class cytometry offering.

  6. FDA Approves GlaxoSmithKline’s Tanzeum For Type 2 Diabetes

    GlaxoSmithKline (GSK) announced in a press release that the Food and Drug Administration (FDA) has approved Tanzeum (albiglutide).

  7. Cubist Pharmaceuticals Issues Voluntary Recall Of Cubicin

    Cubist Pharmaceuticals announced that it has issued a voluntary recall of one lot of Cubicin (daptomycin for injection) due to the presence of particulate matter, identified specifically as glass particles.

  8. Weekly FDA Enforcement Report For Drugs And Biologics 4/16/14

    The Food and Drug Administration (FDA) has released its Drug and Biological product Enforcement Report for April 16, 2014.

  9. Proposed California State Drug-Disposal Law Scrapped

    Last week, legislators killed the bill known as SB 1014 proposed by California state senator Hannah-Beth Jackson that would have required drug companies to create and finance a state-wide system for safely collecting and disposing of unwanted prescription drugs.

  10. Price Of Specialty Drugs Increasing, Report Finds

    According to a new report released by the IMS Institute for Healthcare Informatics, the cost of specialty drugs will continue to increase.